Dissertation > Excellent graduate degree dissertation topics show

Influence of Puerarin on Reproductive System of Sexually Matured Female Mice and Its Development of Embryo-fetus

Author: WangYuJie
Tutor: YuChaoQin
School: Second Military Medical University
Course: Traditional Chinese Medicine
Keywords: Puerarin Phytoestrogens Reproductive system Reproductive toxicity
CLC: R285.5
Type: Master's thesis
Year: 2011
Downloads: 62
Quote: 0
Read: Download Dissertation

Abstract


Objective: To observe the different doses of puerarin female Kunming mice reproductive system, sexual maturity and the development of the mouse embryo - fetal explore the puerarin reproductive period mice mode of action and its reproductive toxicity, as Pueraria factors in clinical applications to provide experimental evidence. Research methods: (1) mice were observed through the vaginal smear estrous cycle, changes in uterine weight gain was observed in mice uterus, enzyme-linked immunosorbent assay serum estradiol (estradiol given E2) and follicle-stimulating hormone (follicle-stimulating hormone, FSH), luteinizing hormone (luteinizing hormone, LH) and other changes in estrogen levels to assess the impact of puerarin on sexually mature female of Kunming mice reproductive system. 8.9-week-old female Kunming mice 40, according to the random number table, were randomly divided into four groups: low-dose puerarin group (150mg/kg), high dose puerarin group (450mg/kg), diethylstilbestrol group ( 35mg/kg), solvent control group (sodium carboxymethyl cellulose), in each group were administered orally, once a day, every time 0.2ml. 08:00 am daily vaginal smears check, observe and record the changes of the estrous cycle in mice. Weekly weighing the body weight of mice, the mice in each group drug dosage adjusted according to body weight. Administered continuously for 6 weeks, 24 hours after ending administration before estrous, orbital blood, the mice were sacrificed by cervical, fast to said take the wet weight of the uterus, ovaries, uterus coefficient were calculated, ovarian coefficient. All serum samples were stored at -20 ℃, the side of the ovary, uterus quickly move stored at -80 ℃, the other side of the ovary, uterus placed in a solution of 10% formalin fixed paraffin slice HE staining uterine histopathological changes. (2) on pregnant female mice from embryonic implantation to the hard palate closure (mouse pregnancy 6-15 days) treated with different doses of puerarin pregnant female mice, embryonic and fetal assessment puerarin. The experiment 160 Kunming mice 8-9 weeks of age, male and female, according to the random number table female mice were randomly divided into four groups, each group of 20. The same kind of the same month-old male and female mice in the same cage at a 1:1 ratio, to start the next day in the same cage, observe whether the female vaginal opening vaginal plug at 08:00 am every day, for no obvious vaginal plug small mouse vaginal smear should be done to check the presence or absence of live sperm in the female vagina. If it is found that the vaginal plug or vaginal smear sperm positive, given as gestational 0d cages of two weeks, administered orally on days 6-15 of pregnancy. 18 days of pregnancy, cervical dislocation killed pregnant rats, fetal mice separated from the uterus to the top, whether the visual inspection stillbirth absorbed fetus, statistics of the number of live births each nest, check live births with or without the appearance of deformity, bone deformities, visceral malformations calculate the average weight of each nest live births, and average crown to rump length of fetal rat measured with a vernier caliper. Results: (1) Weight: low-dose puerarin group weight was significantly lower than the control group (p lt; 0.05), significantly lower than the high dose the puerarin group Diethylstilbestrol group (p lt; 0.01), high-dose puerarin group, no statistically significant difference between the the diethylstilbestrol group and the control group. (2) organ coefficient: ovarian coefficient between groups was not statistically different; uterine coefficient, diethylstilbestrol uterus coefficient significantly higher than the low-dose puerarin group and the control group (p lt; 0.01), significantly higher than the high dose of Pueraria vegetarian group (p lt; 0.05), low dose puerarin uterus coefficient is lower than that of the control group, but no significant difference in the high-dose puerarin group was higher. (3) mouse estrous cycle: 42 days gavage puerarin group, low-dose, the puerarin group of high-dose, diethylstilbestrol group, the control group of mice estrous cycle disorder rates were 70%, 80%, 100% , 0, showing that low-dose puerarin, high-dose puerarin, diethylstilbestrol could cause the mouse estrous cycle disorders, low dose puerarin group and high dose group of puerarin the estrous cycle disorders was significantly lower than the diethylstilbestrol group. (4) the level of serum E2: low-dose puerarin group was significantly lower than the control group (p lt; 0.05), puerarin group was significantly lower than the high-dose, and diethylstilbestrol group (p lt; 0.01), high-dose puerarin group and diethylstilbestrol group significantly higher than the control group (p lt; 0.01), high doses of puerarin group was significantly lower than the the Diethylstilbestrol group (p lt; 0.01). (5) the level of serum FSH: low-dose puerarin group was significantly lower than the the puerarin group of high-dose, the diethylstilbestrol group and control group (p lt; 0.01), high-dose puerarin group and diethylstilbestrol group was significantly higher than that of the control group and the low dose Pueraria was no significant difference between the hormone group (p lt; 0.01), high dose puerarin group and diethylstilbestrol group. (6) serum LH levels: low-dose puerarin group was significantly lower than that of the high-dose puerarin group, the Diethylstilbestrol group (p lt; 0.01), significantly lower than the control group (p lt; 0.05), high-dose puerarin group and diethylstilbestrol group puerarin group was significantly higher than that of the control group and the low dose (p lt; 0.01), no statistically significant difference between the puerarin group and diethylstilbestrol group of high-dose. (7) The uterine histopathological examination: diethylstilbestrol group uterine hypertrophy, interstitial edema of the endometrial tissue, glands increase in the number of bending enlarged glandular different morphological cell proliferation of the glandular epithelium was tall columnar pseudostratified basal layer slightly thickened, low-dose puerarin group, high dose puerarin group and the control group were not similar histological features. (8) endometrial thickness: diethylstilbestrol group endometrial thickness was significantly higher than the low dose Pueraria group, high dose puerarin group and the control group (p lt; 0.01), low-dose puerarin group, high-dose puerarin group and the control was no significant difference between the groups. (9) pregnant rats weight: 6, 9, 12, 15 days of pregnancy weight was no significant difference between the groups; 18 days of pregnancy weight, diethylstilbestrol group was significantly lower than the control group (p lt; 0.01), significantly lower low dose puerarin group and high dose puerarin group (p lt; 0.05), the puerarin group of low-dose and high-dose puerarin group and the control group was not statistically significant. (10) mouse embryo formation: the number of live births, low dose puerarin group, high dose puerarin group, the number of live births, lower than the normal group, but no significant difference was significantly higher than the the Diethylstilbestrol group (p lt; 0.05) high, no statistically significant difference between the low-dose puerarin group. The the diethylstilbestrol group was significantly lower than the control group (p lt; 0.01); absorbed fetus was no significant difference between the groups; each group were no stillbirths. (11) mouse fetal development: average fetal weight, low-dose puerarin group lower than the high dose puerarin group and the control group, but no significant difference diethylstilbestrol puerarin group was higher than that of high-dose group, lower than the normal group , but no significant difference between the diethylstilbestrol group was significantly lower than the control group (p lt; 0.01); The average fetal crown to rump length, low-dose puerarin group than in the high-dose puerarin group and the control group, higher than the diethylstilbestrol group but no statistics learning differences, high-dose puerarin group than diethylstilbestrol group, lower than the normal group, but no significant difference The diethylstilbestrol was significantly lower than the control group (p lt; 0.01); research conclusions: (1) under the experimental conditions, puerarin on the reproductive system of sexual maturity in mice have the dual role of a certain effect, of puerarin due dose different play estrogen and anti-estrogen. (2) during pregnancy females I puerarin gavage of dams and offspring mice had no significant adverse effects, namely puerarin there is no obvious embryos fetal developmental toxicity.

Related Dissertations

  1. The Study of the Effects of Isoflavones of Puerarin and Daidzein on Bone Metabolism in Ovariectomized Female Rats,R580
  2. Linuron SD rats induced embryonic testis development of the overall level of gene expression studies,Q75
  3. The Experimental Study about Protective Effects of Puerarin on Liver of Brain-dead Rats,R285
  4. Therapeutic Effects of BMSCs Combined Puerarin to Treatment Cerebral Ischemia in Rat,R285.5
  5. Different Solid Phase Extraction Methods of Drinking Water of the Organic Matter in Comparison and Analysis of Its Male Reproductive Toxicity,R123.1
  6. Dendritic polymer polyamide - the amine - puerarin Composites and its impact on the cornea,R944
  7. Eight kinds of drugs and eight kinds of infusions and puerarin stability of compatibility with the SMI,R942
  8. The Effect and Potential Mechanism of CP and SP on Hepatoma Carcinoma SMMC-7721 Cell,R735.7
  9. Exploration of Salivary Therapeutic Drug Monitioring in TCM Injections,R286
  10. Effects of Different Doses of Puerarin on Proliferation and Migration of Vascular Endothelial Cell from Human Umbilical Cord Blood,R285.6
  11. Effects of Thorn Formononetin on Expression of Estrogen Receptor α, β in Cerebral Cortex of Ovariectomized Rats,R285.5
  12. In Vitro Study on the Toxicity of Polybrominated Diphenyl Ethers,R114
  13. Establishment of Ovary Cell Line from Barfin Flounder, Verasper Moseri, and Their Toxicity Treated by Endocrine Disruption Chemicals,S917.4
  14. Study of CT Diagnosis and CT Perfusion on Female Pelvic Tumors and Tumor-like Lesions,R737.3
  15. The Effect of Zinc on the Expression of C-fos and C-jun in Spermatogenic Cell in Rats Exposed to Fluorine,R595
  16. Preparation, Characterization of PAMAM Dendrimers-coated Liposomes and Evaluation for Ophthalmic Drug Delivery,R283
  17. The Effect of Peurarin Pretreatment on Endothelial Nitric Oxide Synthase in Brain Tissue and Protective Mechanisms of It on Brain in the Early Stage of Cerebral Ischemia in Rat,R285.5
  18. Study on Quality Control and Pharmacokenetics of Xinnaoliantong Capsual,R285
  19. The Effect of Chinese Medicine on Oxygen Free Radicals and Trace Element in Acute Lung Injure,R285
  20. Calcium Phosphate and Titanium Dioxide (tiO2 ) Nanoparticles Affected Hormone Production and Cell Cycle in `granulosa Cells,R114
  21. Male Reproductive Endocrine Hormone Disturbance of Exposure to Phytoestrogens,R131

CLC: > Medicine, health > Chinese Medicine > Of Pharmacy > Pharmacology > Chinese medicine Experimental Pharmacology
© 2012 www.DissertationTopic.Net  Mobile